Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
ChristianaCare also ranks as No. 2 overall health care employer nationwide for diversity and inclusion, No. 40 overall For the second consecutive year, Forbes magazine has ranked ChristianaCare as one of the best employers for diversity and inclusion in the United States in its list of Best Employers for Diversity 2022. ChristianaCare ranked as the No. 2 employer for diversity and inclusion in the health care industry and the No. 40 employer in the nation overall. “Through purposeful actions, we commit to valuing diversity and fostering an environment for inclusion as we support all caregivers and serve all our neighbors with love and excellence, in our actions and in our words,” said Neil Jasani, M.D., MBA, FACEP, chief people officer at ChristianaCare. “We know when we support our caregivers and they can be their authentic selves, they will be exceptional today and even better tomorrow.” ChristianaCare, Delaware’s largest private employer, has committed to being an anti-racism organization and works to ensure that commitment is reflected through the organization’s policies, programs, and practices. (Read more about ChristianaCare’s anti-racism commitment here.) All employees of ChristianaCare are referred to as caregivers, whether they provide direct patient care or support that care indirectly. ChristianaCare’s inclusion efforts include 10 employee resource groups, which connect caregivers who have a common interest or bond with one another. Formed by employees across all demographics – such as disability, gender, race, military status, national origin, sexual orientation, etc. – these voluntary grassroots groups work to improve inclusion and diversity at ChristianaCare. More than 1,100 caregivers at ChristianaCare participate in employee resource groups. ChristianaCare also has developed LeadershipDNA, a leadership development program that is specifically targeted to underrepresented, diverse populations early in their leadership journey within the organization and is designed to foster professional and career development. ChristianaCare President and CEO Janice E. Nevin, M.D., MPH, has signed the CEO Act!on for Diversity & Inclusion Pledge, which outlines a specific set of actions the signatory CEOs will take to cultivate a trusting environment where all ideas are welcomed, and employees feel comfortable and empowered to have discussions about diversity and inclusion. More than 1,600 of ChristianaCare’s caregivers have also signed the pledge. “This recognition shows that we are making progress in our commitment to invest in our caregivers and to make all who join us feel included,” said Pamela Ridgeway, chief diversity officer and vice president of talent at ChristianaCare. “Taking care of people is what we do, and our ability to help people achieve optimal health is tied directly to how successful we are at embracing diversity and creating an inclusive environment for our caregivers.” Forbes’ Best Employers for Diversity were identified from an independent survey of more than 60,000 U.S. employees working for companies employing at least 1,000 people in their U.S. operations. Respondents were asked to rate their organizations on criteria such as age, disability, ethnicity, gender and sexual orientation equality, as well as general diversity. More than 10,000 companies were reviewed and approximately 2,000 were given a diversity score that is derived from employee surveys and publicly available information. The final list ranks the 500 employers that not only received the most recommendations, but also have the most diverse boards and executive leadership, and the most proactive diversity and inclusion initiatives.
Findings point to potential new therapeutic targets for this highly aggressive, drug-resistant breast cancer subtype In breakthrough research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, scientists have discovered that a protein secreted by tumor cells can switch off the body’s natural defenses against triple negative breast cancer (TNBC). The study, led by Jennifer Sims-Mourtada, Ph.D., lead research scientist at the Cawley Center for Translational Cancer Research (CTCR), at the Graham Cancer Center, is reported in The Journal of Translational Medicine, available online. “What we found is that TNBC tumor cells can effectively shut down the body’s defense systems against the tumor by secreting a type of protein called IL-10,” Dr. Sims-Mourtada said. “The presence of this immune system protein forces the antibodies that would normally be created to attack the tumor to become non-reactive and not do what they are supposed to do.” The study was initiated in partnership with The Wistar Institute of Philadelphia, Pennsylvania, in collaboration with the late Raj “Shyam” Somasundaram, Ph.D., a cell biologist at the Melanoma Research Center. “Dr. Sims-Mourtada and her team have brought us tantalizingly close to understanding what drives the aggressive nature of triple negative breast cancer, a treatment-starved disease that disproportionately affects Delaware women,” said Nicholas J. Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute. “Their work underscores our belief that scientific collaborations such as this one between our Cawley CTCR clinicians and Wistar scientists can smooth the way for new findings to become effective therapies, especially for hard-to-treat and aggressive forms of cancer like TNBC.” Understanding the mechanism behind TNBC Delaware ranks highest in the nation for incidence of triple negative breast cancer. TNBC is an aggressive form that affects Black women at twice the rate of white women with poorer outcomes. Patients have higher rates of early recurrence than other breast cancer subtypes, particularly in the first five years after diagnosis. Currently there is no targeted therapy for TNBC. “One of our missions within the Cawley CTCR is to understand the mechanisms behind TNBC and find a treatment for it,” Dr. Sims-Mourtada said. “Our study sheds new light on what is prompting the body’s immune response to the cancer cells and offers clues to potential new therapeutic targets.” Normally it is the job of the B cells to regulate the immune response against foreign invaders like cancer. Among other jobs, they control inflammation at the site of an attack by releasing proteins including IL-10 to signal the defender cells to stand down. “Previously it was thought that the immune cells were the ones to express IL-10 to regulate themselves,” Dr. Sims-Mourtada said. “But our study shows that the tumor cells also release this protein, which means they are driving how the immune system behaves.” Within the tumor microenvironment, IgG4 is one of four antibody subclasses expressed and secreted by B cells. Whereas another type of antibody would urge the immune system to press on with the attack, activation of IgG4 signals the job is done. TNBC and activation of IgG4 “Our findings support that TNBC may create a tumor environment that supports activation of IgG4, and messaging from IL10 is triggering the switch,” Dr. Sims-Mourtada said. As previously reported with other cancers, such as melanoma, this study confirms that the presence of IgG4-positive B cells within the tumor associates with advanced disease increased recurrence and poor overall breast cancer survival. It is also possible that IL-10 expression by tumor cells may also be a cause of poor outcomes in TNBC, and this may be independent of IgG4+ B cells. “At this point, we don’t know what causes tumor cells to start secreting IL-10, but we know that B cell-tumor cell interactions are involved,” Dr. Sims-Mourtada said. “We still have to look at what is really going on in the B cell population to determine which subtypes of B cells are affected by this tumor crosstalk and why some forms of TNBC express IL-10 (the ones with poor outcomes) and others do not. “We think that the presence or absence of other immune cells in the microenvironment may affect how B cells interact with tumor cells to drive IL-10 expression,” she said. Resources for the study, including blood and tissue samples from consenting patients, were obtained through the Graham Cancer Center’s Tissue Procurement program. Interestingly, in a small subset of samples, the researchers found that IL-10 expression was significantly higher in Black patients than non-Hispanic white patients. These findings need to be confirmed in a larger more diverse population with different TNBC subtypes. Understanding tumor-infiltrating B cells “Our growing understanding of the contribution of IgG4+ cells to the immune microenvironment of TNBC and what drives IL-10 expression may reveal ways in which tumor-infiltrating B cells can contribute to tumor growth and provide new targets to increase the immune response to TNBC,” Dr. Sims-Mourtada said. As partners for more than a decade, Graham Cancer Center research clinicians and Wistar scientists collaborate across disciplines to translate cancer research into more effective therapies for patients everywhere. In addition to providing high-quality, viable tissue samples for Wistar research studies, Graham Cancer Center clinicians actively participate in concept development, sharing their unique understanding of the everyday patient experience.
Aston Institute of Health and Neurodevelopment officially launches new £2.8m MRI scanner
A new £2.8 million MRI scanner has been unveiled at Aston University. The showcase took place in Aston Institute of Health and Neurodevelopment on Monday 25 April. The event was attended by Aston University Interim Vice-Chancellor Saskia Loer Hansen and other members of the University executive team, together with academic researchers in the University’s College of Health and Life Sciences. After an official ribbon-cutting ceremony hosted by the Institute co-directors Professor Jackie Blissett and Professor Gavin Woodhall, guests were invited to take a tour of the new MRI scanner facilities where imaging researchers were on hand to showcase and discuss their research for which the new MRI scanner is a vital facility. Interim Vice-Chancellor Saskia Loer Hansen said: “I am delighted that Aston Institute of Health and Neurodevelopment is home to this state-of-the-art facility. Having a new MRI scanner on our campus will not only enable our scientists to undertake their neuroimaging research, but will also benefit so many patients in the region who urgently need this facility as part of their medical treatment. “Our new MRI scanner further highlights the world-class research that our scientists are undertaking at Aston University.” The new Siemens MAGNETOM Prisma 3T MRI scanner was installed over a period of four months starting in November 2021, including the work undertaken to remove the old machine from the building. The scanner has been made ‘child friendly’ with suitable images and the room which hosts the scanner has a wall mural of cherry blossom trees. The new MRI scanner will enhance the world-class neuroimaging research facilities within the Institute of Health and Neurodevelopment and support the development of the next generation of researchers. Professor Jackie Blissett, co-director of Aston Institute of Health and Neurodevelopment, said: “The new MRI scanner will enhance the world-class neuroimaging research facilities within the Institute of Health and Neurodevelopment. It will allow us to answer the questions that matter to children and young people, their families and the services that support them.” Aston University researchers use advanced neuroimaging techniques to examine brain health in children with neurological diseases and developmental disorders and are developing a research programme focused on children and young people to deliver a new understanding of development, disorder and disease and the interventions that will make a difference. The new scanner will also enable the Institute to provide the most recent innovations in MRI for patients visiting through the clinical service Aston University Imaging. Patients visiting for MRI scans come through private referrals, as well as from local institutions such as the Birmingham Royal Ballet and Aston Villa Football Club.
What the CDC's Updated Developmental Guidelines Mean for Parents
The Centers for Disease Control and Prevention (CDC) recently revamped their developmental guidelines for children for the first time in years, allowing parents to know earlier if their kids may be experiencing any delays. Villanova University nursing professor Michelle Kelly, PhD, CRNP, CNE, recently commented on the new guidelines: "The CDC and American Academy of Pediatrics (AAP), in response to birth provider and parent input, took a critical look at existing developmental milestones tools and handouts. Surveillance and handouts are typically parent facing items that can be used to determine if a child is meeting age-expected developmental targets." "That is in contrast to screening which is more structured, based on the surveillance but done by a primary care provider and used for referral for services, and evaluation which is done by a developmental specialist with the intent to diagnosis." "The CDC and AAP have done a thorough overhaul of developmental milestone surveillance (as opposed to screening and evaluation) to attempt to make the milestones 'evidence-based' and where possible norm-referenced." "Another major change is that the milestones are set for greater than 75%, rather than 50%. This means they are targets that 75% of children that age would have met. This eliminates phrases in the previous milestones that were confusing, such as a child 'may begin' a task at one age, but also should be doing it at the next age." "Perhaps the biggest win for children born preterm and others at risk for developmental delays is the 75% expectation virtually eliminates the 'wait and see' that occurred when the expectation was that 50% of children would exhibit a skill at that age. This means that families who have concerns, or whose children are not meeting the age-appropriate milestones, should be more readily referred for evaluation and intervention." "Additionally, an increased emphasis is placed, compared to the previous version, on open-ended questions to elicit parent concerns and ways for families to promote age-appropriate development."
The research looked into the means for achieving higher sustainability performance through circular economy adoption The project was led by Professor Prasanta Dey and Professor Pawan Budhwar from Aston Business School Data was gathered from around 100 SMEs from Greece, France, Spain and the UK. New findings from an Aston University-led study have found Small and Medium Sized Enterprises (SMEs) are likely to achieve higher environmental performance through circular economy (CE) adoption. CE is a systemic approach to economic development designed to benefit businesses, society, and the environment. In contrast to the 'take-make-waste' linear model, a circular economy is regenerative by design and aims to gradually decouple growth from the consumption of finite resources. The project was led by Professor Prasanta Dey and Professor Pawan Budhwar from Aston Business School along with Soumyadeb Chowdhury (Toulouse Business School), Krishnendu Saha (Birmingham City University), Debashree De (University of Essex) and Chrysovalantis Malesios (Agricultural University of Athens). Data was gathered from around 100 SMEs from each of the four selected countries – Greece, France, Spain and the UK using a survey to study the current state of CE adoption, and subsequently, focus groups were organised which involved SMEs owners and managers, policymakers, SMEs' customers and suppliers, in each country to derive means for improving sustainability performance. The study reveals that SMEs in all the participating countries are likely to achieve higher environmental performance through CE adoption. SMEs in France were likely to achieve higher overall sustainability performance than other participating countries. It also found products, processes and facilities design is likely to help SMEs most in all the participating countries to adopt CE, while their waste management all needed improvement. Professor Budhwar, head of Aston Business School, said: “Although from prior research there is evidence of SMEs achieving superior environmental performance by adopting CE, economic and social performances are not assured. This motivated us to undertake empirical research to reveal the means for achieving higher sustainability performance (economic, environmental, and social) through CE adoption”. “The findings of this research enable us to continue CE adoption not only in other European countries but also in India, Thailand, Vietnam and Kenya”. Professor Dey, a professor in operations and information management at Aston Business School, said: “SMEs in the EU countries are likely to have sustainable design practices aligned with the CE philosophy. On the contrary, SMEs in the participating countries are likely to have worst recover function. “This implies that customers' pressure works for SMEs to adopt CE principles as design function in most of the SMEs' businesses is governed by SMEs' customers. Whereas effective recover function depends on SMEs' self-motivation and policymakers’ pressure.” “CE adoption needs a structured approach of analysing current state of CE through analysing correlation of organisational value functions with sustainability performance, identifying issues and challenges, and suggesting means for improvement across value functions.” You can read the full report here.
Aston MBA students take top prize at Universities Business Challenge Global Masters 2022
The competition helps develop the skills needed to move into corporate/public sector life The Grand Final took place in Liverpool where 10 teams from different universities competed for the title They were assessed on their team strengths and presented a one-minute pitch on a creative social business idea to an entrepreneur. A team of Aston MBA students has taken the top prize at the Universities Business Challenge (UBC) Global Masters 2022. Team GE7, which included Aishwarya Nagath Menon, Nashit Khalifa, Vasilijs Garbacevics, Divya Krisitipati led by Mithun Joy and mentored by Aston Business School’s Dr Julius Stephan, will receive a trophy on campus on 12 May. The competition offers postgraduate students a unique opportunity to develop the skills that you will need when moving into the working world and consists of 80 teams, drawn from a wide range of UK and Irish universities. The UBC Global Masters is a team-based business simulation event that provides participants with the opportunity to act as a board of directors, who have taken responsibility for improving the performance of a company. The finals took place in Liverpool where 10 teams from different universities, including two from Aston University, competed against each other tasked to run a simulated business under difficult trading conditions and also introduce an innovative idea to link the business to a social or environmental cause. The teams were assessed on their team strengths and presented a one-minute pitch on a creative social business idea to an entrepreneur. Mithun Joy, an Aston MBA student and team winner, said: “I am really proud to be part of the first Aston Business School team to win this competition. “It was a really competitive event against other universities, including the UBC's defending champion.” Clive Kerridge, course director at Aston Business School, said: “Although an Aston University MSc team made the podium in 2022, we are delighted to have our first ever winners of this excellent competition. “Taking part in the UBC Global Masters Challenge has been a great opportunity for our students to apply their theoretical knowledge to a complex, yet highly practical and topical business setting. “It allows for personal and professional development that is intellectually challenging and practically relevant, equipping participants with essential skills. Working in competitive teams enables peer to peer learning and interaction.” Find out more about the competition here.
Aston University appoints translator in residence to inspire future literary translators
Aston University and Writing West Midlands have appointed Sarah Letza, a professional translator from the region to the role She will be working on community engagement activities at Aston University and with the West Midlands community The project is funded by Arts Council England. Aston University has appointed a translator in residence as part of a project developed by the translators Daniel Hahn and Ros Schwartz, a new one-off literary translation residency for 2022 based in Birmingham. Sarah Letza, a professional translator from the region, has been appointed to the position until March 2023. The project is funded by Arts Council England and will be run in partnership with Aston University and Writing West Midlands. Sarah’s residency will encourage an interest in literary translation and translated literature, and the valuing of languages, among communities in and around Birmingham through workshops, talks and other public engagement and collaborative participation projects. Sarah Letza, translator in residence at Aston University, said: “I hope to draw attention to the opportunities that translation and language learning can lead to and capitalise on the wealth of talent that can be drawn from Midlands schools and universities. “There is the potential to be involved with the many translation research projects already under development at Aston University as well as promoting and supporting languages and translation pathways. “I want to showcase Birmingham as a city that has been built on cultural crossings, intellectual exchange and creativity, all of which are the bedrock of both translation and language learning.” Dr David Orrego-Carmona, a lecturer in English, languages and applied linguistics at Aston University, said: “Birmingham is an incredibly multilingual city and Aston University is particularly well-placed to raise awareness and showcase the value of languages, translation and intercultural exchanges. “We are certain the programme will provide inspiring experiences for our beneficiaries in Birmingham and the region, and we are looking forward to the engaging activities that Sarah is already planning.” For more information about our courses in translation click here.
Aston University MEG scanning facilities used by start-up to launch new brain health service
MEG scanning services at Aston Institute of Health and Neurodevelopment (IHN) have been used to launch the world’s first brain-imaging service to measure and assess brain health. Commercial brain imaging service Myndspan launched a service to assess brain health and identify concussions, with an event at Aston University. Start-up, MYndspan, was founded in 2020 by Caitlin Baltzer, former vice president of operations at functional brain imaging company Croton Healthcare and Janne Huhtala, previously chief executive of MEGIN, the global leader in functional brain imaging. The service was created to support brain health across populations, using cutting edge brain scanning technology to monitor and extend healthy cognitive lifespans. The brain imaging service is powered by a non-invasive brain scanning technology called Magnetoencephalography (MEG), which measures the electrical signals between neurons to form a highly detailed map of brain activity and function. The MEG scanner, which is located in the Aston Institute of Health and Neurodevelopment, at Aston University, identifies and observes functional ‘invisible injuries’ to the brain, such as concussion or PTSD, that can’t be seen from an MRI image of the brain. MYndspan’s service combines MEG scans with gamified tests of cognitive function, which measure a range of mental processes such as attention, memory, and visuospatial processing. Using these two measures of brain health, cognitive function and brain function, MYndspan provides a comprehensive overview, detailed in a thorough, easy-to-understand report of how a person’s brain is behaving and why. Among the service’s first customers are neuroscientist and author Dr Dean Burnett who is using MYndspan to monitor the effect increasing physical activity has on his brain over time and Vicky Macqueen former England Rugby player and chief executive of Didi Rugby, who is using the service to measure her pre-concussion baseline for playing contact sports safely. Through routine monitoring of personal brain activity, MYndspan helps people assess and understand their brain health. This helps to identify issues before symptoms emerge and supports optimal lifestyle and clinical intervention. Its first application is concussion, where the technology can support the recovery of an estimated 3.8 million athletes who experience sports-related concussion annually. Janne Huhtala, MYndspan co-founder said: “MYndspan’s technology can identify concussed brain activity and objectively identify and monitor recovery from a concussion. Currently, individuals are deciding to go back to play based on how they feel – a decision that can have life changing consequences. “We think athletes deserve to have objective information about where they are in their recovery, to make the best and most informed decisions.” MYndspan’s service will be available to the general public at Aston University’s Institute of Health and Neurodevelopment (IHN), an international leader in advanced technology to explore brains, development and healthy behaviours. IHN at Aston University is the first of many planned locations around the world where individuals will be able to access the service. MYndspan co-founder Caitlin Baltzer added: “The brain is hugely complex and exciting, and whilst there is a vast body of research and knowledge already available, there is still so much for us to learn about how it functions and changes over time. “In a world where we can track and optimise every part of our health, and our lives, the brain remains neglected. At MYndspan, we believe that every person has the right to better brain health and this begins with knowing our brains. “We are very excited to launch our brain scanning technology at Aston University as a demonstration for how digital health tools can support brain health and ultimately help more people recover and age better.” Dr Dean Burnett, neuroscientist and author, including of the Guardian blog ‘Brain Flapping’, said: “I'm a big proponent of anything that helps people understand their brains better, and MYndspan's new high-tech but easily accessible approach looks to be extremely useful in that regard.”
Sweeteners may be linked to increased cancer risk – new research
Sweeteners have long been suggested to be bad for our health. Studies have linked consuming too many sweeteners with conditions such as obesity, type 2 diabetes and cardiovascular disease. But links with cancer have been less certain. An artificial sweetener, called cyclamate, that was sold in the US in the 1970s was shown to increase bladder cancer in rats. However, human physiology is very different from rats, and observational studies failed to find a link between the sweetener and cancer risk in humans. Despite this, the media continued to report a link between sweeteners and cancer. But now, a study published in PLOS Medicine which looked at over 100,000 people, has shown that those who consume high levels of some sweeteners have a small increase in their risk of developing certain types of cancer. To assess their intake of artificial sweeteners, the researchers asked the participants to keep a food diary. Around half of the participants were followed for more than eight years. The study reported that aspartame and acesulfame K, in particular, were associated with increased cancer risk – especially breast and obesity-related cancers, such as colorectal, stomach and prostate cancers. This suggests that removing some types of sweeteners from your diet may reduce the risk of cancer. Cancer risk Many common foods contain sweeteners. These food additives mimic the effect of sugar on our taste receptors, providing intense sweetness with no or very few calories. Some sweeteners occur naturally (such as stevia or yacon syrup). Others, such as aspartame, are artificial. Although they have few or no calories, sweeteners still have an effect on our health. For example, aspartame turns into formaldehyde (a known carcinogen) when the body digests it. This could potentially see it accumulate in cells and cause them to become cancerous. Our cells are hard-wired to self-destruct when they become cancerous. But aspartame has been shown to “switch off” the genes that tell cancer cells to do this. Other sweeteners, including sucralose and saccharin, have also been shown to damage DNA, which can lead to cancer. But this has only been shown in cells in a dish rather than in a living organism. Sweeteners can also have a profound effect on the bacteria that live in our gut. Changing the bacteria in the gut can impair the immune system, which could mean they no longer identify and remove cancerous cells. But it’s still unclear from these animal and cell-based experiments precisely how sweeteners initiate or support cancerous changes to cells. Many of these experiments would also be difficult to apply to humans because the amount of sweetener was given at much higher doses than a human would ever consume. The results from previous research studies are limited, largely because most studies on this subject have only observed the effect of consuming sweeteners without comparing against a group that hasn’t consumed any sweeteners. A recent systematic review of almost 600,000 participants even concluded there was limited evidence to suggest heavy consumption of artificial sweeteners may increase the risk of certain cancers. A review in the BMJ came to a similar conclusion. Although the findings of this recent study certainly warrant further research, it’s important to acknowledge the study’s limitations. First, food diaries can be unreliable because people aren’t always honest about what they eat or they may forget what they have consumed. Although this study collected food diaries every six months, there’s still a risk people weren’t always accurately recording what they were eating and drinking. Though the researchers partially mitigated this risk by having participants take photos of the food they ate, people still might not have included all the foods they ate. Based on current evidence, it’s generally agreed that using artificial sweeteners is associated with increased body weight – though researchers aren’t quite certain whether sweeteners directly cause this to happen. Although this recent study took people’s body mass index into account, it’s possible that changes in body fat may have contributed to the development of many of these types of cancers – not necessarily the sweeteners themselves. Finally, the risk of developing cancer in those who consumed the highest levels of artificial sweeteners compared with those who consumed the lowest amounts was modest – with only at 13% higher relative risk of developing cancer in the study period. So although people who consumed the highest amounts of sweetener had an increased risk of developing cancer, this was still only slightly higher than those with the lowest intake. While the link between sweetener use and diseases, including cancer, is still controversial, it’s important to note that not all sweeteners are equal. While sweeteners such as aspartame and saccharin may be associated with ill health, not all sweeteners are. Stevia, produced from the Stevia rebaudiana plant, has been reported to be useful in controlling diabetes and body weight, and may also lower blood pressure. The naturally occurring sugar alcohol, xylitol, may also support the immune system and digestion. Both stevia and xylitol have also been shown to protect from tooth decay, possibly because they kill bad oral bacteria. So the important choice may be not the amount of sweetener you eat but the type you use.
Technical training, exposure to multiple industries and an open and inclusive culture help IT Associates innovate across CCG. They are often the quiet contributors to a project, taking a business idea from concept to delivery to allow strategic business endeavours to get off the ground. What they do and how they do it can be mysterious to many, with technical jargon, architectural details and complex processes at play. To succeed in IT requires incredible technical knowledge, a solid understanding of business processes, and innovative mindset with a natural curiosity to understand how multiple industry business systems all work together. Most importantly what’s needed is the desire for continuous learning. The IT department at CCG has enjoyed an incredible period of growth and development over recent years. In the last decade alone, CCG has undergone a major technology transformation, replacing every major business system required to support the different lines of business under the CCG umbrella including CAA Insurance, Orion Travel Insurance, CAA Travel, Membership and Emergency Roadside Services, while also implementing industry-leading innovations like CAA MyPace. We spoke to three tenured Associates to uncover their secret to success working in IT. What drives the culture of a team that often works behind the scenes but is vital to the success of all organizational projects? Lindsay Lamothe Typically, IT Associates have exposure to many business areas, giving them a well-rounded view of the various industries in which CCG operates. At first glance, one might think that this kind of exposure helps drive innovation and growth. But, while this is true for many, Lindsay Lamothe, Senior Business Systems Analyst for CCG’s Roadside Product Management, explains it’s more nuanced. “I think working in multiple lines of business at the organization led me down the path towards IT. I have no formal training in IT but having exposure to the business side of things gave me insights that continue to be valuable now that I work in a business enablement area,” shared Lamothe. “Being exposed to multiple industries while working in IT is a valuable opportunity to grow knowledge, but I think anyone who can learn more about the multiple industries we operate in would be well-positioned to do well in IT.” Lamothe started at CCG as a summer student to pay for university and eventually came on full-time working in auto travel, helping Members with TripTiks. She worked on the frontlines for ten years before shifting into IT and roadside assistance and has now been at the company full-time for 18 years. Her sense of purpose comes through very clearly when you speak to her about the impact of her work. “I am proud to work in IT at CCG because I am passionate about roadside operations. What we do saves lives,” said Lamothe. “If each code fix or enhancement that we work on gets us to the Member even five seconds sooner, that could be a matter of life or death. I know that we are making a difference in people's lives.” Voytek Bialkowski Voytek Bialkowski, just accepted a promotion to a director position in Enterprise Resource Planning. He also started his career at CCG and credits the technical learning opportunities offered for his continued success. Next month he marks the impressive milestone of 15 years with the company. “CCG is unparalleled in the marketplace in terms of professional growth and learning opportunities,” shares Bialkowski. “Our senior leaders have created a true knowledge culture by encouraging and celebrating professional development, certification, and lifelong learning. In my time with the IT department, I have earned four SAP certifications that furthered my technical skillset. I have also leveraged many of the programs available for Associates, such as the Lean Six Sigma White Belt and the Queens mental health certificate.” What truly sets CCG’s IT department apart is the emphasis on technical training that many Associates can receive right out of school or with little prior knowledge. Bialkowski explains, “CCG has provided me with multiple avenues for technological growth. Working on best-in-class systems and learning their functional and technical components has allowed me to become intimately familiar with SAP’s software suite, Greenfield SAP strategies and methodologies, data quality and data migration, application management, software development and testing lifecycle, as well as SQL and other query languages.” It's clear through the experiences of Lamothe and Bialkowski that learning opportunities and a broad array of opportunities to contribute to different areas of the business are key drivers of the success of CCG’s IT Associates. While hard skills and insights are essential, equally important is the culture of a team and the people that one works with to get things done. John Zhao John Zhao, Manager Quality Assurance in IT App Development & Architecture, shared his take on CCG’s culture and how that plays a role in delivering exceptional service to CCG’s business areas. “Collaboration and mutual respect underpin everything we do in IT. This is a big part of how we continue to learn and support each other,” shares Zhao. “Beyond these two values, we are encouraged to apply innovation to our daily process and products.” Innovation, being care-driven, leading by example, and collaboration are values that define CCG’s corporate culture across departments. Still, it is evident in speaking to Zhao that with tight deadlines and often unexpected challenges, they are especially engrained in the culture and approach of the IT department. Zhao’s experience at CCG aligns with Bialkowski and Lamothe’s, showcasing how fostering and developing technical knowledge internally and maintaining a broad perspective that can connect the dots across multiple industries are standard features of our IT approach. All three Associates underscore how the innovative and best-in-class approach of our IT department starts at the top. From Jay Woo, our CEO, to Apra Sekhon, our Chief Innovation Officer and Kin Lee-Yow, our Chief Information Officer, and their leaders. Together, they set the bar on integrating technology and innovation to ensure everyone aligns on promoting growth and knowledge to drive success for CCG’s IT Associates. As technology and innovation continue to grow, it’s valuable for all Associates to understand how this hardworking group of individuals support the essential work we do at CCG.
